EUVIMEDEUVIMED entdecken
Open Access

Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy

George Haddad, Johan M Lorenzen, Hong Ma, Noortje de Haan, Harald Seeger, Christelle Zaghrini, Simone Brandt, Malte Kölling, Urs Wegmann, Bence Kiss, Gábor Pál, Péter Gál und 6 weitere

Journal of Clinical Investigation · 01.03.2021 · 131 (5)

DOI: 10.1172/jci140453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.03.2021. Verfasst von George Haddad und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, University of Zurich, Switzerland. Die Arbeit wurde bisher 180-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAutoantibodiesAutoimmune DiseasesCarrier ProteinsCell Line, TransformedComplement Membrane Attack ComplexComplement Pathway, Mannose-Binding LectinGlomerulonephritis, MembranousHumansImmunoglobulin GMembrane ProteinsMicrofilament ProteinsNephrotic SyndromePodocytesReceptor, Anaphylatoxin C5aReceptors, ComplementReceptors, Phospholipase A2

Stichwörter der Autor:innen

Chronic kidney diseaseComplementGlycobiologyImmunologyNephrology

Substanzen

AutoantibodiesC5AR1 protein, humanCarrier ProteinsComplement Membrane Attack ComplexImmunoglobulin GKIRREL1 protein, humanKIRREL3 protein, humanMembrane ProteinsMicrofilament ProteinsPLA2R1 protein, human

Autor:innen und Institutionen

  • Institute of Physiology, University of Zurich, Switzerland.
  • Division of Nephrology, University Hospital of Zurich, Switzerland.
  • Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Center for Proteomics and Metabolomics, Leiden University Medical Center, Netherlands.
  • Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne Sophia Antipolis, France.
  • Institute of Pathology, University Hospital of Zurich, Switzerland.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Haddad, G., Lorenzen, J. M., Ma, H., de Haan, N., Seeger, H., Zaghrini, C., Brandt, S., Kölling, M., Wegmann, U., Kiss, B., Pál, G., Gál, P., Wüthrich, R. P., Wuhrer, M., Beck, L. H., Salant, D. J., Lambeau, G., & Kistler, A. D. (2021). Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy. Journal of Clinical Investigation, 131(5). https://doi.org/10.1172/jci140453

Vancouver

Haddad G, Lorenzen JM, Ma H, de Haan N, Seeger H, Zaghrini C, et al. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy. Journal of Clinical Investigation. 2021;131(5). doi:10.1172/jci140453

BibTeX
@article{Haddad2021,
  author = {Haddad, George and Lorenzen, Johan M and Ma, Hong and de Haan, Noortje and Seeger, Harald and Zaghrini, Christelle and Brandt, Simone and Kölling, Malte and Wegmann, Urs and Kiss, Bence and Pál, Gábor and Gál, Péter and Wüthrich, Rudolf P and Wuhrer, Manfred and Beck, Laurence H and Salant, David J and Lambeau, Gérard and Kistler, Andreas D},
  title = {Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy},
  journal = {Journal of Clinical Investigation},
  year = {2021},
  volume = {131},
  number = {5},
  doi = {10.1172/jci140453}
}
Kostenlos starten →